Key takeaways
- Melatonin is the only sleep supplement with strong evidence — but specifically for jet lag and circadian phase shift, not chronic insomnia (Cochrane review).
- A JAMA analysis found melatonin gummies' actual content varied widely from label claims, and some products contained undisclosed CBD — a quality problem, not just an efficacy one.
- Magnesium for insomnia rests on just 3 RCTs in 151 older adults, rated low-to-very-low quality evidence (systematic review, PMC8053283).
- Glycine (~3g before bed) and L-theanine show promising but small-study effects on subjective sleep quality — not proven at guideline level.
- ZMA, homeopathic sleep remedies, "natural Ambien" herbal blends, and CBD sleep gummies are the biggest hype-to-evidence gaps: a recent trial found acute ZMA gave no sleep benefit and even reduced some sleep measures in replete men.
Among sleep supplements, melatonin has the clearest evidence for jet lag and circadian phase shifting, while magnesium and glycine have limited but plausible evidence for selected people; none should replace CBT-I for chronic insomnia or evaluation for sleep apnea. Popular “sleep gummy” blends, ZMA muscle-sleep claims, homeopathic sleep remedies, CBD sleep overclaims, valerian as a “natural Ambien,” and proprietary multi-ingredient sedative stacks are weaker than their marketing suggests (Cochrane melatonin review, AASM pharmacologic insomnia guideline, NIH/NCCIH sleep approaches). The safest evidence-based strategy is to match the supplement to the actual sleep problem, check interactions, and avoid using sedating blends to cover up apnea, severe daytime sleepiness, or medication-related insomnia.
Table of contents
- Evidence summary
- Bottom-line verdict table
- Independent evidence and funding map
- What sleep supplements can and cannot do
- All forms and types of sleep supplements
- Proven or plausible ingredients
- Popular ingredients and claims with weak evidence
- All side effects
- All interactions
- Who should avoid sleep supplements
- Frequently asked questions
- Sources
Evidence summary
| Claim | Evidence | Primary source | Funding / conflict trace | Strength |
|---|---|---|---|---|
| Melatonin prevents or reduces jet lag. | Cochrane review found melatonin effective, especially for adults crossing 5 or more time zones and eastward travel. | Cochrane melatonin jet-lag review | Probably independent review; older underlying trials have incomplete funding details. | Works |
| Melatonin is not a strong chronic adult insomnia treatment. | AASM suggests clinicians not use melatonin for sleep-onset or sleep-maintenance insomnia in adults. | AASM pharmacologic insomnia guideline | Independent professional guideline; recommendation is weak because evidence certainty is limited. | Doesn't as routine insomnia treatment |
| Melatonin gummies/blends may be mislabeled. | JAMA analysis of gummies found measured melatonin varied widely from labeled amounts, with some products also containing CBD. | JAMA gummy analysis | Probably independent consumer-safety testing; not an efficacy study; one retail-market sample. | Strong quality warning |
| Magnesium for insomnia has weak evidence. | Systematic review identified 3 RCTs in 151 older adults and rated evidence low to very low quality. | Magnesium insomnia review | Academic review; small trial base with limited methods and generalizability. | Mixed / weak |
| Glycine before bed is promising but small-study evidence. | Small human studies report improved subjective sleep quality and next-day performance after sleep restriction. | Glycine sleep-restriction study; Glycine mechanism paper | Small studies; some ingredient-interest research; needs larger independent replication. | Promising limited |
| Valerian evidence is inconsistent and not guideline-supported for chronic insomnia. | AASM suggests not using valerian for adult insomnia; systematic reviews find heterogeneity and inconsistent outcomes. | AASM pharmacologic guideline; Valerian meta-analysis | Product variability and publication bias risk; many trials have incomplete funding disclosures. | Weak |
| Tart cherry may help some insomnia outcomes, but evidence is small and product-specific. | Pilot crossover trials in older adults with insomnia tested tart cherry juice and reported improvements in selected outcomes. | Tart cherry pilot trial; Tart cherry insomnia trial | Small samples; proprietary juice products or industry-linked material in some studies. | Limited |
| L-theanine may help stress arousal, but sleep evidence is mixed. | ADHD and stress studies suggest possible sleep or relaxation effects, while broader reviews find inconsistent sleep results. | L-theanine review; GAD trial | Several positive trials use branded ingredients or industry funding; independent replication limited. | Mixed |
| Ashwagandha sleep evidence is positive but conflict-sensitive. | Systematic review/meta-analysis found benefit, but underlying trials often used branded extracts and short durations. | Ashwagandha sleep meta-analysis | Many extract trials have product sponsors, supplied materials, or incomplete disclosures. | Promising, downgraded |
| CBD sleep claims are ahead of evidence. | Small RCTs show mixed or preliminary findings; CBD has meaningful drug-interaction and liver-safety concerns. | 150 mg CBD insomnia pilot trial; StatPearls CBD | Some cannabinoid trials are product-linked or pilot-sized; regulatory status varies globally and is not addressed here. | Overclaimed |
| ZMA is not proven as a sleep-enhancing muscle formula. | Recent acute ZMA trials in men found no clear sleep benefit and in some settings reduced sleep measures. | ZMA sleep study | Sports-nutrition claim with small trial base; not a strong insomnia evidence pathway. | Doesn't |
Bottom-line verdict table
| Ingredient / claim | Verdict | Best use-case if any | Main caveat |
|---|---|---|---|
| Melatonin | WORKS for jet lag and circadian phase shift | Timed short-term use for jet lag or delayed sleep timing. | Not a stronger sleeping pill; timing and dose discipline matter. |
| Magnesium | MIXED | Low intake/status, older adults, cramps from deficiency, constipation with laxative forms. | Insomnia evidence is weak; kidney disease and drug interactions matter. |
| Glycine | PROMISING BUT LIMITED | Sleep quality and next-day fatigue in small studies. | Needs larger independent trials; not for medicated psychiatric conditions without supervision. |
| Valerian / hops | WEAK | No strong evidence-based insomnia role. | Sedation interactions still matter despite weak efficacy. |
| Tart cherry | LIMITED | Food-based option for selected adults who tolerate juice/concentrate. | Small trials, sugar/GI considerations, and product-specific evidence. |
| L-theanine | MIXED | Stress-related arousal or calm focus, not a hypnotic. | Industry-linked evidence common; caffeine stacks can backfire. |
| Ashwagandha | PROMISING BUT DOWNGRADED | Stress-related sleep complaints in short-term trials. | Pregnancy, liver, thyroid, autoimmune, and sedative cautions. |
| CBD sleep gummies/oils | OVERCLAIMED | Research context only unless clinician-guided. | Drug interactions and liver risks are more serious than wellness marketing suggests. |
| ZMA muscle-sleep formula | DOESN'T | No clear evidence-based sleep role for people with adequate intake. | Correct deficiencies individually instead of buying a mythic stack. |
| Homeopathic sleep remedies | NO GOOD EVIDENCE | No evidence-based role for persistent insomnia. | Case reports and small trials do not establish efficacy. |
| “Natural Ambien” blends | MISLEADING | None as a claim. | Ambien-like claims imply drug-level sedation without drug-level evidence or safety controls. |
Text version of this infographic
| Tier | Ingredients or claims | Meaning |
|---|---|---|
| Best-supported | Melatonin for jet lag or circadian phase shift; correcting true nutrient deficiencies. | Evidence matches a defined mechanism or need. |
| Plausible / limited | Magnesium, glycine, tart cherry, L-theanine, ashwagandha. | May help selected people, but evidence is small, mixed, or conflict-sensitive. |
| Overclaimed | ZMA sleep myth, homeopathy, “natural Ambien” claims, CBD gummies/oils, mega-blends. | Marketing is stronger than independent evidence. |
Independent evidence and funding map
| Source | Country / scope | Evidence type | Independence rating | Credibility rank | Likely motivation |
|---|---|---|---|---|---|
| Cochrane melatonin jet-lag review | International trials | Systematic review | Probably independent | Strong | Maintain transparent evidence-synthesis credibility. |
| AASM pharmacologic insomnia guideline | International literature | Clinical guideline | Independent guideline; underlying drug/supplement trials vary | Strong | Standardize care and reduce ineffective insomnia prescribing. |
| Magnesium insomnia review | Older-adult trials in multiple countries | Systematic review/meta-analysis | Probably independent | Moderate | Academic clarification of a popular claim; limited by tiny trial base. |
| JAMA melatonin gummy analysis | One retail market | Analytical chemistry study | Probably independent | Strong for quality concerns | Consumer-label accountability; not proof of benefit. |
| Ashwagandha sleep meta-analysis | International trials | Systematic review/meta-analysis | Mixed because trial base often has extract/product interests | Moderate | Academic synthesis; conclusions need sponsor-aware downgrading. |
| NCCIH sleep complementary approaches | Public-health reference | Evidence and safety summary | Independent government health information | Strong | Public education and adverse-event prevention. |
| CBD 150 mg primary insomnia pilot | Australia | Randomized controlled pilot trial | Moderate; pilot-sized, product context must be checked | Moderate-low | Clinical research into a popular sleep claim; underpowered for broad conclusions. |
Money and influence map: Ingredient brands benefit when small positive trials become broad claims. The evidence filter used here is: independent guideline or review first, then RCTs, then sponsor and author-conflict checks, then safety references. Product-funded trials are not automatically false, but they are downgraded until independently replicated.
What sleep supplements can and cannot do
Sleep supplements can send a timing signal, correct a deficiency, mildly reduce arousal, or create sedation. They cannot create adequate sleep opportunity, undo late caffeine reliably, treat chronic insomnia conditioning, cure untreated sleep apnea, or make a stressful schedule physiologically harmless. This is why a supplement that helps jet lag can still fail for chronic insomnia. The right question is not “What is the strongest sleep supplement?” The right question is “What sleep problem is present?” Melatonin fits circadian timing; magnesium fits deficiency or specific medical uses; glycine and L-theanine fit mild arousal or subjective sleep-quality hypotheses; sedative herbs and cannabinoid products need much stronger safety and efficacy evidence before they should be treated as routine sleep solutions.All forms and grades
| Form/type | What it is | Best-case rationale | Main evidence problem | Verdict |
|---|---|---|---|---|
| Single-ingredient melatonin | Immediate-release, prolonged-release, sublingual, liquid, or gummy melatonin. | Circadian timing signal for jet lag or phase shift. | Quality and dose variability; wrong timing can fail. | Use only for timing goals |
| Mineral supplements | Magnesium glycinate, citrate, oxide, chloride, threonate, and blends with zinc. | Correct low intake/status or laxative use depending on form. | Sleep claims exceed evidence; threonate and ZMA marketing are especially overextended. | Form-specific |
| Amino acids | Glycine and L-theanine as powders, capsules, or drink ingredients. | May reduce arousal or improve subjective sleep quality in small studies. | Small trials and frequent branded-ingredient involvement. | Promising but limited |
| Herbal extracts | Valerian, hops, passionflower, lemon balm, chamomile, ashwagandha. | Sedation, stress adaptation, or traditional use. | Extract variability, small trials, unclear active dose, sponsor effects. | Mostly weak or conflict-sensitive |
| Food-derived sleep products | Tart cherry juice/concentrate, kiwi, milk peptides, herbal teas. | Food matrix, melatonin/tryptophan/polyphenol hypotheses. | Small trials; product-specific dosing; sugar/GI issues. | Low-risk for some, not proven therapy |
| CBD/cannabinoid products | CBD alone or combined with THC, CBN, terpenes, or botanicals. | May affect anxiety, pain, arousal, or sleep continuity in selected contexts. | Pilot trials, heterogeneous cannabinoid mixes, drug interactions, liver concerns. | Overclaimed |
| Sleep gummies and proprietary blends | Multi-ingredient chewables with melatonin, herbs, amino acids, magnesium, or cannabinoids. | Convenience and stacking mechanisms. | Label accuracy, hidden sedation, interaction stacking, underdosed or overdosed ingredients. | Downgrade unless transparent and tested |
| Homeopathic sleep remedies | Highly diluted preparations selected by symptom patterns or sold as sleep formulas. | Placebo/context effects, ritual, expectation. | No robust evidence for persistent insomnia; case reports do not prove efficacy. | No evidence-based role |
Text version of this infographic
- If the problem is wrong clock timing, melatonin timing is the best-supported supplement approach.
- If the problem is low magnesium intake or status, magnesium may be relevant, but the form and medical context matter.
- If the problem is mild arousal or stress, glycine or L-theanine is plausible but not proven as a strong insomnia treatment.
- If the problem is snoring, gasping, witnessed pauses, or daytime sleepiness, do not self-sedate; seek sleep-apnea evaluation.
Proven or plausible ingredients
Melatonin: proven for timing, overused for insomnia
Melatonin is a circadian signal. Cochrane concluded it is effective for preventing or reducing jet lag and that occasional short-term use appears safe in adults (Cochrane melatonin review). AASM, however, suggests clinicians not use melatonin for adult sleep-onset or sleep-maintenance insomnia, which means melatonin is not a general replacement for CBT-I (AASM pharmacologic guideline). Forms: immediate-release, prolonged-release, sublingual, liquid, chewable/gummy, and combination blends. Immediate-release better matches a short timing signal; prolonged-release is more relevant to sleep-maintenance hypotheses; gummies are convenient but raise quality and child-access concerns. A JAMA analysis found substantial label mismatch in melatonin gummies, making transparent third-party testing more important than flavor or dose size (JAMA gummy analysis).Magnesium: useful mineral, weak sleep pill
Magnesium is essential for nerve and muscle function, and NIH notes that more soluble forms such as citrate, chloride, lactate, and aspartate tend to be better absorbed than oxide or sulfate (NIH ODS magnesium). The insomnia evidence is much weaker: a systematic review of oral magnesium for insomnia in older adults found only 3 RCTs and low-to-very-low-quality evidence (magnesium insomnia review). Forms: glycinate/bisglycinate, citrate, oxide, chloride, lactate, aspartate, malate, taurate, L-threonate, sulfate, and orotate. Glycinate is popular for sleep because it is often gentler; citrate is more laxative; oxide is cheap but poorly soluble; threonate sleep claims are not independently established enough to justify premium claims.Glycine: promising, small-study support
Glycine is a nonessential amino acid that may influence sleep through thermoregulation and NMDA-receptor pathways; mechanistic research links glycine’s sleep-promoting and hypothermic effects to NMDA receptors in the suprachiasmatic nucleus (glycine mechanism paper). Human evidence is small but promising: studies report improved subjective daytime performance after partial sleep restriction and refer to prior findings that glycine improved subjective and objective sleep quality in people with sleep complaints (glycine sleep-restriction study). Forms: glycine powder, capsules/tablets, collagen peptides rich in glycine, and multi-ingredient blends. Pure glycine is easier to dose; collagen peptides are food-like but not equivalent to a defined glycine dose.Tart cherry: food-based but not proven therapy
Tart cherry juice has small placebo-controlled crossover studies in older adults with insomnia, including a pilot trial of a proprietary tart cherry juice blend and a later trial investigating mechanisms (tart cherry pilot trial, tart cherry insomnia trial). The evidence is interesting but too small and product-specific to call tart cherry a proven insomnia treatment.L-theanine: arousal support, not a hypnotic
L-theanine is best framed as calm-focus or stress-arousal support rather than a direct sleeping pill. A review found inconsistent sleep evidence, and a generalized anxiety disorder trial did not show a clear anxiety advantage over placebo even though some sleep-satisfaction measures improved (L-theanine review, GAD trial).Ashwagandha: promising but conflict-sensitive
A systematic review and meta-analysis reported that ashwagandha extract improved sleep outcomes versus placebo, but confidence is downgraded because many trials are short, use branded extracts, and involve sponsor or product-supply relationships (ashwagandha sleep meta-analysis). NCCIH notes potential short-term safety but insufficient long-term safety data, along with drowsiness, GI effects, rare liver injury, pregnancy concerns, and thyroid/autoimmune cautions (NCCIH ashwagandha).Text version of this infographic
- Highest confidence: independent guidelines or systematic reviews supported by consistent randomized trials.
- Moderate confidence: small independent randomized trials with meaningful sleep outcomes.
- Lower confidence: sponsor-funded or branded-ingredient trials that need independent replication.
- Lowest confidence: testimonials, proprietary blend logic, tradition, or homeopathic case reports.
Popular ingredients and claims with weak evidence
ZMA muscle-sleep myth
ZMA combines zinc, magnesium aspartate, and vitamin B6 and is often sold as a recovery, testosterone, or sleep formula. A recent trial in males with adequate dietary intake and no sleep disturbance found acute ZMA did not provide a clear sleep advantage and reduced some sleep measures in the study context (ZMA study). If zinc, magnesium, or B6 intake is low, correct the deficiency specifically; do not assume a branded stack improves sleep in replete people.Sleep gummy blends
Gummies encourage casual dosing of active compounds and often combine melatonin with herbs, magnesium, L-theanine, or cannabinoids. The JAMA gummy analysis is a quality warning because measured melatonin content varied widely from labels, and some products contained CBD (JAMA gummy analysis). A blend also makes side effects harder to trace: morning grogginess could come from melatonin dose, valerian, antihistamine-like botanicals, cannabinoids, alcohol interaction, or the combination.Homeopathic sleep remedies
Homeopathic sleep evidence is not strong enough for persistent insomnia. Published evidence includes case reports and small trials in narrow populations, which cannot establish reliable efficacy for chronic insomnia (homeopathy insomnia case report, homeopathic polysomnography study). The biggest risk is not direct toxicity from ultra-dilute products; it is delaying effective care for insomnia, apnea, depression, pain, or medication-related sleep disruption.CBD sleep overclaims
CBD is widely marketed for sleep, but the sleep evidence remains preliminary and heterogeneous. A 150 mg CBD randomized pilot trial in primary insomnia was small, and cannabinoid trials often mix CBD with THC, CBN, terpenes, or other active compounds, making ingredient-specific claims difficult (CBD insomnia pilot, cannabinoid insomnia trial). CBD also has meaningful safety issues, including dose-dependent liver toxicity and drug interactions via metabolism pathways (StatPearls CBD).Valerian as “natural Ambien”
Valerian is not natural Ambien. AASM suggests clinicians not use valerian for adult sleep-onset or sleep-maintenance insomnia, and NCCIH notes side effects and warns against combining valerian with alcohol or sedatives because of possible sleep-inducing effects (AASM pharmacologic guideline, NCCIH valerian). A weakly effective sedative herb can still create real interaction risk.All side effects
| Ingredient | Common side effects | Rare but serious concerns | At-risk populations | Independent source |
|---|---|---|---|---|
| Melatonin | Sleepiness, headache, dizziness, nausea, vivid dreams. | Uncertain long-term pediatric endocrine effects; mood or seizure concerns in susceptible people; next-day impairment if overdosed. | Children, pregnancy/lactation, seizure disorder, autoimmune disease, people taking sedatives or anticoagulants. | NCCIH melatonin |
| Magnesium | Diarrhea, nausea, abdominal cramping; citrate and oxide are more laxative. | Hypermagnesemia with low blood pressure, confusion, arrhythmia, respiratory depression in kidney impairment or excessive intake. | Kidney disease, older adults with reduced kidney function, people taking multiple magnesium-containing products. | NIH ODS magnesium |
| Glycine | GI discomfort, nausea, soft stools, possible sleepiness in some users. | High-dose psychiatric use may interact unpredictably with antipsychotic regimens; clozapine adjunct data raise concern. | People with schizophrenia or antipsychotic therapy, pregnancy/lactation, kidney/liver disease without clinician input. | Clozapine-glycine trial |
| Valerian / hops | Headache, stomach upset, mental dullness, excitability, uneasiness, vivid dreams. | Excess sedation; rare liver-injury reports are hard to attribute in multi-ingredient products. | Sedative users, alcohol use, pregnancy/lactation, liver disease, safety-sensitive work. | NCCIH valerian |
| Tart cherry | GI discomfort, reflux, loose stool; sugar load for juice products. | Interaction data are sparse; high intake may matter for medically managed blood sugar or potassium-sensitive diets depending on product. | Diabetes management, kidney disease with potassium restriction, GI sensitivity, anticoagulant users until clinician-cleared. | Tart cherry pilot trial |
| L-theanine | Headache, GI symptoms, dizziness-like symptoms, changes in alertness; caffeine-containing stacks add caffeine effects. | Human safety data are mostly short-term; rare reactions may be missed. | Blood-pressure medication users, sedative users, stimulant users, pregnancy/lactation. | L-theanine safety trial; L-theanine review |
| Ashwagandha | Drowsiness, stomach upset, diarrhea, vomiting. | Rare liver injury; thyroid hormone effects; pregnancy risk. | Pregnancy, liver disease, thyroid disease, autoimmune disease, sedative users. | NCCIH ashwagandha; LiverTox |
| CBD / cannabinoid products | Fatigue, drowsiness, diarrhea, GI discomfort, appetite changes. | Liver enzyme elevations, hepatotoxicity risk with interacting medicines, next-day impairment when combined with THC or sedatives. | Liver disease, pregnancy/lactation, sedative users, anticoagulant or anticonvulsant users, people taking narrow-therapeutic-index drugs. | StatPearls CBD; CBD liver-toxicity review |
All interactions
| Ingredient | Interacts with | Mechanism / concern | Severity | Action |
|---|---|---|---|---|
| Melatonin | Sedatives, alcohol, opioids, benzodiazepines, Z-drugs, sedating antihistamines | Additive sedation and next-day impairment. | Avoid / supervise | Do not combine for self-treatment. |
| Melatonin | Anticoagulants/antiplatelets; diabetes medicines; antihypertensives; immunosuppressants; seizure medicines | Possible bleeding, glucose, blood pressure, immune, or seizure-threshold concerns. | Caution | Use only with clinician input if medically managed. |
| Magnesium | Tetracycline and quinolone antibiotics | Mineral binding reduces antibiotic absorption. | Separate | Separate by the medicine label’s instructed interval. |
| Magnesium | Bisphosphonates, thyroid medication, iron, zinc, calcium | Mineral competition or binding may reduce absorption. | Separate / monitor | Take medicines and minerals at separated times. |
| Magnesium | Diuretics, PPIs, kidney disease | Can alter magnesium balance or clearance. | Monitor | Discuss magnesium testing and dose safety. |
| Glycine | Clozapine and psychiatric medication regimens | High-dose glycine did not help clozapine patients and preliminary data suggested possible antagonism of clozapine response. | Medical supervision | Do not add glycine for sleep if taking antipsychotics without the prescriber. |
| Valerian / hops | Alcohol, benzodiazepines, Z-drugs, opioids, sedating antihistamines, other sleep herbs | Additive CNS depression and next-day impairment. | Avoid | Do not stack sedatives. |
| L-theanine | Antihypertensives, sedatives, stimulants, high caffeine intake | Possible BP lowering, additive calming/sedation, or caffeine-driven insomnia in stacks. | Caution | Separate from stimulant-heavy blends; monitor BP if treated. |
| Ashwagandha | Sedatives, thyroid medicines, immunosuppressants, hepatotoxic medicines, alcohol | Drowsiness, thyroid effects, immune activity, and liver-injury concern. | Avoid / supervise | Avoid in pregnancy and liver disease; clinician input for thyroid/autoimmune disease. |
| CBD | Anticonvulsants, anticoagulants, antidepressants, antipsychotics, opioids, benzodiazepines, alcohol, immunosuppressants, hepatotoxic medicines | CYP metabolism effects, additive sedation, and liver-enzyme concerns. | Medical supervision | Do not use casual CBD sleep products with prescription medicines without clinician/pharmacist review. |
| Tart cherry | Anticoagulants, diabetes medicines, potassium-sensitive kidney/heart regimens | Evidence is sparse; sugar/polyphenol/potassium context may matter by product and diet. | Caution when medically managed | Treat as a food exposure but ask if on restricted diets or anticoagulants. |
Text version of this infographic
| Risk cluster | Examples | Action |
|---|---|---|
| Sedation stack | Melatonin, valerian/hops, CBD/THC, alcohol, benzodiazepines, Z-drugs, opioids, sedating antihistamines. | Avoid combining for self-treatment. |
| Absorption stack | Magnesium with antibiotics, bisphosphonates, thyroid medication, iron, zinc, or calcium. | Separate doses by medication instructions. |
| Liver/metabolism stack | CBD or ashwagandha with alcohol, hepatotoxic medicines, anticonvulsants, anticoagulants, or immunosuppressants. | Use only with clinician/pharmacist review. |
Who should avoid sleep supplements
Avoid self-prescribing sleep supplements and seek medical guidance first if pregnant or lactating, under 18, older with falls or cognitive impairment, taking sedatives/opioids/anticoagulants/antiepileptics/immunosuppressants/thyroid medicines, living with kidney disease, liver disease, bipolar disorder, seizure disorder, autoimmune disease, or thyroid disease, or experiencing snoring with gasping, witnessed pauses, or daytime sleepiness. These groups have higher risk from interactions, side effects, wrong diagnosis, or delayed care.Pure City verdict: If one supplement is worth knowing, it is melatonin—but for timing, not blanket insomnia. If one category is worth avoiding, it is proprietary sedative blends that hide dose logic and stack interactions.
Frequently asked questions
What sleep supplement has the best evidence?
Melatonin has the best practical evidence for jet lag and circadian phase shifting, not for routine chronic adult insomnia. Cochrane supports melatonin for jet lag, while AASM suggests not using melatonin as a chronic insomnia treatment in adults (Cochrane melatonin review, AASM pharmacologic guideline).
Is magnesium good for sleep?
Magnesium may help if intake or status is low, but insomnia evidence is weak. A review found only 3 RCTs in older adults and rated evidence low to very low quality (magnesium insomnia review).
Does glycine work for sleep?
Glycine is promising but not proven at guideline level. Small studies report subjective sleep-quality and next-day performance benefits, while mechanistic work suggests effects through thermoregulation and NMDA-related pathways (glycine sleep-restriction study, glycine mechanism paper).
Are sleep gummies safe?
Not automatically. Gummies can be mislabeled, easy to overuse, attractive to children, and often combine several sedating or interacting ingredients; JAMA testing found large differences between labeled and measured melatonin in gummies (JAMA gummy analysis).
Is valerian a natural Ambien?
No. AASM suggests not using valerian for adult sleep-onset or sleep-maintenance insomnia, and NCCIH warns against combining it with alcohol or sedatives because it may have sleep-inducing effects (AASM pharmacologic guideline, NCCIH valerian).
Does CBD help sleep?
CBD sleep evidence is preliminary and over-marketed. Small pilot trials cannot establish broad benefit, and CBD has meaningful interaction and liver-safety concerns (CBD insomnia pilot, StatPearls CBD).
Does ZMA improve sleep and muscle recovery?
Not convincingly for people with adequate dietary intake. A recent study in males with adequate dietary needs found no clear sleep benefit from acute ZMA and reported reductions in some sleep measures in the study context (ZMA study).
Are homeopathic sleep remedies evidence-based?
No strong evidence supports homeopathic remedies for persistent insomnia. Published evidence includes case reports and small narrow trials, which are not enough to replace CBT-I or evaluation for underlying sleep disorders (homeopathy case report, homeopathic polysomnography study).
Can I combine multiple sleep supplements?
Stacking sleep supplements increases interaction uncertainty and makes side effects harder to trace. Avoid combining melatonin, valerian/hops, CBD/THC, alcohol, sedatives, opioids, or sedating antihistamines unless a qualified clinician has reviewed the full list.
Sources
- Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane
- Sateia MJ, et al. AASM pharmacologic treatment guideline for chronic insomnia in adults. PubMed
- NCCIH. Sleep Disorders and Complementary Health Approaches. NCCIH
- Cohen PA, et al. Quantity of Melatonin and CBD in Melatonin Gummies. PMC
- Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults. PMC
- NIH Office of Dietary Supplements. Magnesium Fact Sheet. NIH ODS
- Bannai M, et al. Glycine and sleep-related daytime performance. PMC
- Kawai N, et al. Glycine sleep-promoting and hypothermic effects. PMC
- Bent S, et al. Valerian for sleep: systematic review and meta-analysis. PMC
- NCCIH. Valerian: Usefulness and Safety. NCCIH
- Pigeon WR, et al. Tart cherry juice beverage and sleep in older adults with insomnia. PMC
- Losso JN, et al. Tart cherry juice for insomnia and mechanisms. PMC
- Moshfeghinia R, et al. L-theanine systematic review. PMC
- Sarris J, et al. L-theanine adjunctive trial in generalized anxiety disorder. PubMed
- Cheah KL, et al. Ashwagandha extract and sleep systematic review/meta-analysis. PMC
- NCCIH. Ashwagandha. NCCIH
- LiverTox. Ashwagandha. NCBI Bookshelf
- Hayley A, et al. Nightly 150 mg CBD in primary insomnia pilot RCT. PMC
- Walsh JH, et al. Cannabinoid medicine for chronic insomnia symptoms. PMC
- StatPearls. Cannabidiol in Clinical Care. NCBI Bookshelf
- CBD metabolism and liver toxicity review. PMC
- ZMA acute sleep study. PMC
- Homeopathic insomnia case report. PMC
- Homeopathic medicines and polysomnographic sleep. PMC
- Sleep Foundation. Melatonin overview. Sleep Foundation